This project aims to find new biomarkers for immunotherapy in patients with melanoma.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Cancer – Stage IV Melanoma

Study location

Wesley Research Insitute, The Wesley Hospital

Study type

Investigator Initiated

Finding new biomarkers for immunotherapy in patients with melanoma

    Lead investigator    
            Private: Dr Agnieszka Malczewski        

        Clinical trial coordinator		
				Venita Bali			

Technical title

Metabolomics in Enhancing Responses to Cancer ImmunoTherapy in Melanoma (MERIT-M)

About this research project

Cancer immunotherapy has been shown to provide patients with an excellent new type of treatment and is in common use world-wide. Unfortunately, we know that not all patients will respond to their immunotherapy treatment in the same way.

Responses to immunotherapy may be affected by a patient’s microbiome, or the community of bacteria that live in their bowel. This group of bacteria can influence the immune system by increasing or decreasing certain types of white cells, called T cells that are produced in the body. By analysing the bacteria, this project aims to find new biomarkers for immunotherapy in patients with melanoma.

Latest News

Queensland claims world-first Chair in Spatial Medicine

In a landmark move in diagnosing and treating chronic disease, Queensland has unveiled the world’s first Chair in Spatial Medicine – a prestigious, philanthropically-funded research leadership position appointed to Associate Professor Arutha Kulasinghe.

Gluten Threshold Study Findings

WRI researchers have made a groundbreaking discovery showing that even extremely small amounts of gluten can trigger measurable immune activation in people with treated coeliac disease – findings that could help refine international food labelling standards.

How Kira is Helping to Shape Global Coeliac Research

When Kira was invited to participate in the Gluten Threshold Study, led by Coeliac Disease & Immune Health Research Program Clinical Director Dr James Daveson, Kira didn’t hesitate. The study’s findings are expected to influence international food labelling standards – an outcome that gives Kira a genuine sense of purpose.

1 2 3 … 34 Next »